Antibody-based therapeutics have shown remarkable success in the treatment of conditions such as cancer, inflammation and infectious disease. Yet the clinical efficacy of this class of therapeutic ...

Germany's N26 co-founder Tayenthal to step down as co-CEO N26 co-founder Maximilian Tayenthal will step away from his operational duties as co-CEO of the German digital bank on Dec. 31, as the company ...